EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrated Characterization of AP-2δ Reveals Distinct Regulatory Architecture in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma

Damian Kołat iD, Weronika Kruczkowska iD, Żaneta Kałuzińska-Kołat iD, Cromwel Tepap Zemnou iD, Mateusz Kciuk iD, Lin-Yong Zhao, Renata Kontek iD, Elżbieta Płuciennik iD

Cancers · 17.04.2026 · 18 (8) · 1278

DOI: 10.3390/cancers18081278 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 17.04.2026. Verfasst von Damian Kołat und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Functional Genomics, Medical University of Lodz, 90-752 Lodz, Poland. Die Arbeit nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: AP-2δ, encoded by TFAP2D, is one of the least characterized members of the AP-2 transcription factor family, although available evidence suggests biologically relevant roles in lung cancer that have not yet been thoroughly examined. The aim of the present study was to provide an integrated characterization of AP-2δ/TFAP2D in lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC).

Methods

LUAD and LUSC data were obtained from The Cancer Genome Atlas. The analysis comprised the expression profiling of AP-2δ target genes, survival-guided TFAP2D stratification, clinical profiling, differential expression and intersection analyses, methylation-derived chromatin compartment profiling, TFAP2D-associated cofactor rewiring, and genome-wide enrichment of AP-2δ targets. In parallel, pocket prioritization was performed using an AlphaFold model of AP-2δ with cross-tool consensus mapping.

Results

TFAP2D stratification delineated biologically-distinct states in both histological subtypes (LUAD and LUSC). AP-2δ target genes showed subtype-specific expression patterns and functional organization. The consistent survival association was observed for progression-free interval rather than uniformly across all endpoints. Clinical profiling was more closely associated with molecular subtype composition than broad clinicopathological differences. Differential expression analyses identified both shared and histology-dependent programs associated with TFAP2D. In the chromatin-compartment analysis, LUSC showed a broader and more coherent footprint, whereas LUAD displayed more selective cofactor rewiring. Structure-based analysis prioritized a small set of reproducible candidate pockets concentrated within ordered regions of the TF_AP-2 domain.

Conclusions

AP-2δ marks biologically meaningful but histologically non-uniform regulatory states in lung cancer. These findings provide an integrated framework for understanding TFAP2D-dependent regulation in LUAD and LUSC, highlighting AP-2δ as a candidate for future mechanistic and translational investigation.

Schlagwörter

Stichwörter der Autor:innen

AP-2δTFAP2Dbioinformaticschromatin compartmentsclinical profilingdifferential coexpressionexpression patternsligandabilitylung adenocarcinomalung squamous cell carcinoma

Autor:innen und Institutionen

  • Department of Functional Genomics, Medical University of Lodz, 90-752 Lodz, Poland.
  • Department of Molecular Biotechnology and Genetics, University of Lodz, 90-237 Lodz, Poland.
  • International Doctoral School, Medical University of Lodz, Hallera Square 1, 90-647 Lodz, Poland.
  • School of Engineering BioMedTech, EuroMed University of Fes (UEMF), Fes 30070, Morocco.
  • Department of General Surgery, West China Hospital, Sichuan University, Chengdu 610041, China.

ORCID-Profile: Damian Kołat, Weronika Kruczkowska, Żaneta Kałuzińska-Kołat, Cromwel Tepap Zemnou, Mateusz Kciuk, Renata Kontek, Elżbieta Płuciennik

Zitieren

APA

Kołat, D., Kruczkowska, W., Kałuzińska-Kołat, Ż., Zemnou, C. T., Kciuk, M., Zhao, L. Y., Kontek, R., & Płuciennik, E. (2026). Integrated Characterization of AP-2δ Reveals Distinct Regulatory Architecture in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma. Cancers, 18(8), 1278. https://doi.org/10.3390/cancers18081278

Vancouver

Kołat D, Kruczkowska W, Kałuzińska-Kołat Ż, Zemnou CT, Kciuk M, Zhao LY, et al. Integrated Characterization of AP-2δ Reveals Distinct Regulatory Architecture in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma. Cancers. 2026;18(8):1278. doi:10.3390/cancers18081278

BibTeX
@article{Koat2026,
  author = {Kołat, Damian and Kruczkowska, Weronika and Kałuzińska-Kołat, Żaneta and Zemnou, Cromwel Tepap and Kciuk, Mateusz and Zhao, Lin-Yong and Kontek, Renata and Płuciennik, Elżbieta},
  title = {Integrated Characterization of AP-2δ Reveals Distinct Regulatory Architecture in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma},
  journal = {Cancers},
  year = {2026},
  volume = {18},
  number = {8},
  pages = {1278},
  doi = {10.3390/cancers18081278}
}
Kostenlos starten →